Holo, Sweden

Lars-Gunnar Larsson


Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lars-Gunnar Larsson

Introduction

Lars-Gunnar Larsson is a notable inventor based in Holo, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address central nervous system disorders. With a total of 8 patents to his name, Larsson's work has had a meaningful impact on medical treatments.

Latest Patents

Among his latest patents, Larsson has disclosed innovative compounds such as chroman derivatives, specifically 3-amino-5-carbonylchromans, along with their enantiomers and salts. These compounds are particularly useful in the treatment of 5-hydroxytryptamine-mediated disorders of the central nervous system. Additionally, he has developed a method for treating anxiety through the administration of 3-amino-5-carbamoyl-chromans and 8-fluoro-3-amino-5-carbamoylchromans, or their enantiomers and salts.

Career Highlights

Throughout his career, Lars-Gunnar Larsson has worked with prominent companies in the pharmaceutical industry, including Astra Aktiebolag and Aktiebolaget Astra. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.

Collaborations

Larsson has collaborated with several notable individuals in his field, including Svante Bertil Ross and Daniel Dungan Sohn. These partnerships have further enhanced his innovative capabilities and have led to the successful development of his patented compounds.

Conclusion

Lars-Gunnar Larsson's contributions to pharmaceutical innovations demonstrate his commitment to improving treatments for central nervous system disorders. His work continues to influence the medical field and offers hope for effective therapies in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…